Carmel Harrington on butyrylcholinesterase as a potential biomarker for SIDS

eBioMedicine in conversation with
19/07/2022 17 min
Carmel Harrington on butyrylcholinesterase as a potential biomarker for SIDS

Listen "Carmel Harrington on butyrylcholinesterase as a potential biomarker for SIDS"

Descargar episodio

Episode Synopsis

Dr Carmel Harrington joins eBioMedicine to discuss about their findings of a potential biomarker for sudden infant death syndrome.Read the full article:Butyrylcholinesterase is a potential biomarker for Sudden Infant Death SyndromeContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

More episodes of the podcast eBioMedicine in conversation with

Wenqing Li on transcriptome risk scores to decipher susceptibility genes for risk stratification of gastric cancer 07/07/2025
Alisa Clyne and Callie Weber on the impacts of APOE-ε4 and exercise training on brain microvascular endothelial cell barrier function and metabolism 26/02/2025
Boyi Yang on green space and human health 06/11/2024
Lei Chen on scarless burn wound healing 30/09/2024
Torben Hansen on the interplay between birth weight and obesity in determining childhood and adolescent cardiometabolic risk 28/08/2024
Mo Li on PARP inhibitors 04/07/2024
Sanja Jelic & Daniel Gottlieb on the impact of CPAP on biomarkers 30/05/2024
Eddy Pasquier & Marion LeGrand on druggable cancer vulnerabilities 07/11/2023
Alan Dangour on climate change and health 25/09/2023
John Cryan on the microbiome-gut-brain axis and binge drinking 25/07/2023
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA